Condition P14B
Tobacco use
People who smoke or use other tobacco products.
2 randomized trials; 0 fitted analyses across 7 outcomes.
All outcomes
Each outcome is analyzed per time window and estimand, with doses kept apart (each dose) and pooled (each medicine). Analyses with too few connected trials are shown as descriptive.
Serious adverse events
| Time window | Estimand | Treatments | Trials | Nodes | Analysis |
|---|---|---|---|---|---|
| longest follow-up | Recorded harms | Doses of a drug pooled | 1 | 2 | Descriptive only |
| longest follow-up | Recorded harms | Each dose separately | 1 | 2 | Descriptive only |
Discontinuation due to adverse events
| Time window | Estimand | Treatments | Trials | Nodes | Analysis |
|---|---|---|---|---|---|
| longest follow-up | Recorded harms | Each dose separately | 1 | 2 | Descriptive only |
| longest follow-up | Recorded harms | Doses of a drug pooled | 1 | 2 | Descriptive only |
Nausea
| Time window | Estimand | Treatments | Trials | Nodes | Analysis |
|---|---|---|---|---|---|
| longest follow-up | Recorded harms | Doses of a drug pooled | 1 | 2 | Descriptive only |
| longest follow-up | Recorded harms | Each dose separately | 1 | 2 | Descriptive only |
Vomiting
| Time window | Estimand | Treatments | Trials | Nodes | Analysis |
|---|---|---|---|---|---|
| longest follow-up | Recorded harms | Each dose separately | 1 | 2 | Descriptive only |
| longest follow-up | Recorded harms | Doses of a drug pooled | 1 | 2 | Descriptive only |
Diarrhea
| Time window | Estimand | Treatments | Trials | Nodes | Analysis |
|---|---|---|---|---|---|
| longest follow-up | Recorded harms | Doses of a drug pooled | 1 | 2 | Descriptive only |
| longest follow-up | Recorded harms | Each dose separately | 1 | 2 | Descriptive only |
Constipation
| Time window | Estimand | Treatments | Trials | Nodes | Analysis |
|---|---|---|---|---|---|
| longest follow-up | Recorded harms | Each dose separately | 1 | 2 | Descriptive only |
| longest follow-up | Recorded harms | Doses of a drug pooled | 1 | 2 | Descriptive only |
Discontinuation due to gastrointestinal adverse events
| Time window | Estimand | Treatments | Trials | Nodes | Analysis |
|---|---|---|---|---|---|
| longest follow-up | Recorded harms | Each dose separately | 1 | 2 | Descriptive only |
| longest follow-up | Recorded harms | Doses of a drug pooled | 1 | 2 | Descriptive only |